Dr. Basil Darras, MD

• Pediatric Neurology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Yale School Of Medicine

  Fellowship Hospital, 1988

• Tufts Medical School - New England Medical Center

  Residency Hospital, 1985

• Tufts Medical School, New England Medical Center

  Fellowship Hospital, 1985

• Tufts Medical School, New England Medical Center|yale University School Of Medicine

  Fellowship Hospital, 1985

• Nassau County Medical Center, Clinical Campus Suny At Stony Brook

  Residency Hospital, 1982

• Nassau County Medical Center, Clinical Campus Suny At Stony Brook|tufts Medical School - New England Medical Center

  Residency Hospital, 1982

• University Of Athens Hospital

  Internship Hospital, 1979

• University Of Athens, School Of Health Sciences

  Medical School, 1977

• University Of Athens Medical School

  Medical School, 1977

• University Of Athens Medical School|university Of Athens, School Of Health Sciences

  Medical School, 1977

• English

• Greek

• Mutation Spectrum in the Large GTPase Dynamin 2, and Genotype-Phenotype Correlation in Autosomal Dominant Centronuclear Myopathy, 2012-04-04

• Mutations in the satellite cell geneMEGF10cause a recessive congenital myopathy with minicores, 2012-02-28

• The motor neuron response toSMN1deficiency in spinal muscular atrophy, 2014-06-19

• LGMD2I in a North American population, 2007-11-24

• Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool, 2017-02-21

• Novel Mutation inCNTNAP1results in Congenital Hypomyelinating Neuropathy, 2017-02-03

• Developing Standardized Corticosteroid Treatment for Duchenne Muscular Dystrophy, 2017-04-24

• Nusinersen Treatment of Children with Later-Onset Spinal Muscular Atrophy and Scoliosis Is Associated with Improvements or Stabilization of Motor Function†, 2023-07-26

• Loss of electrical anisotropy is an unrecognized feature of dystrophic muscle that may serve as a convenient index of disease status, 2016-10-13

• Compound heterozygosity of predicted loss-of-functionDESvariants in a family with recessive desminopathy, 2013-07-02

• Composite biomarkers for assessing Duchenne muscular dystrophy: an initial assessment, 2014-10-07

• Motor and Cognitive Assessment of Infants and Young Boys with Duchenne Muscular Dystrophy; Results from the Muscular Dystrophy Association DMD Clinical Research Network, 2013-05-28

• Massachusetts' Findings from Statewide Newborn Screening for Spinal Muscular Atrophy, 2021-05-23

• A case of congenital myasthenic syndrome with episodic apnea, 2009-06-19

• Developmental milestones in type I spinal muscular atrophy, 2016-11-01

• Inefficient dystrophin expression after cord blood transplantation in DMD, 2010-10-05

• Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy, 2017-05-04

• One Year Outcome of Boys with Duchenne Muscular Dystrophy Using the Bayley-III Scales of Infant and Toddler Development, 2014-02-15

• Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy, 2017-02-23

• The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States, 2016-10-06

• Outcome Reliability in Non Ambulatory Boys/Men with Duchenne Muscular Dystrophy, 2015-02-11

• Natural History of Infantile-Onset Spinal Muscular Atrophy, 2017-12-08

• Electrical impedance myography for assessment of Duchenne muscular dystrophy, 2017-05-04

• Exome sequencing identifies a novelSMCHD1mutation in facioscapulohumeral muscular dystrophy 2, 2013-08-31

• Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States, 2023-06-06

• Ambulatory function in spinal muscular atrophy: Age-related patterns of progression, 2018-06-26

• Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG) Intrathecal Onasemnogene Abeparvovec for SMA, 2023-03-09

• Optimizing electrical impedance myography measurements by using a multifrequency ratio: a study in Duchenne muscular dystrophy, 2014-05-17

• Inter-session reliability of electrical impedance myography in children in a clinical trial setting, 2014-11-28

• A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial, 2018-05-10

• Cross-sectional evaluation of electrical impedance myography and quantitative ultrasound for the assessment of Duchenne muscular dystrophy in a clinical trial setting, 2014-02-28

• Quantitative Muscle Ultrasound in Duchenne Muscular Dystrophy: A Comparison of Techniques, 2014-12-23

• Assessing Electrical Impedance Alterations in Spinal Muscular Atrophy via the Finite Element Method, 2012-06-26

• Reldesemtivin Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study, 2021-02-23

• Multicenter Consensus Approach to Evaluation of Neonatal Hypotonia in the Genomic Era: A Review, 2022-04-01

• Longitudinal natural history of type I spinal muscular atrophy: a critical review, 2020-04-05

• Automated DNA mutation detection using universal conditions direct sequencing: application to ten muscular dystrophy genes, 2009-10-18

• Exploring the relationship between electrical impedance myography and quantitative ultrasound parameters in Duchenne muscular dystrophy, 2019-02-12

• Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial Deflazacort versus Prednisone/Prednisolone: ACT DMD Trial Analysis, 2018-09-27

• Natural history of Type 1 spinal muscular atrophy: a retrospective, global, multicenter study, 2022-07-29

• Systemic nature of spinal muscular atrophy revealed by studying insurance claims, 2019-03-14

• Identification of a pathogenic mutation inATP2A1via in silico analysis of exome data for cryptic aberrant splice sites, 2019-01-28

• Dysphagia Phenotypes in Spinal Muscular Atrophy: The Past, Present, and Promise for the Future, 2021-04-06

• Medical management of muscle weakness in Duchenne muscular dystrophy, 2020-10-19

• 2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants, 2023-02-28

• Quantitative Ultrasound Assessment of Duchenne Muscular Dystrophy Using Edge Detection Analysis, 2016-07-14